Campus,Year,Session,Subject,Course,Detail,Section,Title,Professor,Enrolled,Avg,High,Low,<50,50-54,55-59,60-63,64-67,68-71,72-75,76-79,80-84,85-89,90-100,Median,Percentile (75),Percentile (25)
UBCV,2022,W,PHRM,333,,001,Pharmacotherapy in Oncology,Shirin Abadi S.a.;Ly Vu;Judy Wong,13,79.1,89.0,70.0,0,0,0,0,0,2,2,1,7,1,0,80.0,83.0,74.0
UBCV,2023,W,PHAR,548,,001,M.Sc. Seminar,Adam Frankel;Kate Johnson;Shyh-Dar Li;Colin Ross;Ly Vu;Judy Wong,28,90.0,90.0,90.0,,,,,,,,,,,,90.0,90.0,90.0
UBCV,2023,W,PHAR,548,,002,M.Sc. Seminar,Adam Frankel;Kate Johnson;Shyh-Dar Li;Colin Ross;Ly Vu;Judy Wong,7,89.5,92.0,87.0,,,,,,,,,,,,89.5,90.75,88.25
UBCV,2023,W,PHRM,311,,001,Medication Management IV,Shirin Abadi S.a.;Jennifer Bolt;Colleen Brady;Brian Cairns;Roxane Carr;Fong Chan;Vaughn Chauvin;Abby Collier;Neelam Dhaliwal;Lynda Eccott;Michelle Fischer;Adam Frankel;Jonathan Grosshuesch;Ali Reza Ladak;Kathleen Lau;Jason Min;Aileen Mira;Janice Lynn Moshenko;Susan North;Ingrid Price;Ric Procyshyn;Tony Seet;Katherine Seto;Adeline Tan;Ly Vu;Judy Wong;Jane Meng Xia,209,79.33,93.0,65.0,0,0,0,0,3,15,28,63,63,32,5,79.0,83.0,76.0
UBCV,2023,W,PHRM,333,,001,Pharmacotherapy in Oncology,Shirin Abadi S.a.;Ly Vu,13,80.69,90.0,70.0,0,0,0,0,0,1,2,1,6,2,1,82.0,84.0,79.0
